Jan 03, 2017 13:01 pm UTC| Business
Therapeutic candidate IVA337 is a next generation PanPPAR agonist addressing all the relevant clinical and regulatory features of NASHNATIVE clinical study plans to enroll 225 patients in 12 European countriesHeadline...
Florida’s Largest Retirement Community Launches 3D, VR-Ready Interactive Map
Jan 03, 2017 13:01 pm UTC| Business
BOULDER, Colo., Jan. 03, 2017 -- concept3D, developer of interactive 3D map and virtual tour software powering immersive online experiences, announced today that Shell Point has launched the company’s atlas3D platform....
Florida’s Largest Retirement Community Launches 3D, VR-Ready Interactive Map
Jan 03, 2017 13:01 pm UTC| Business
BOULDER, Colo., Jan. 03, 2017 -- concept3D, developer of interactive 3D map and virtual tour software powering immersive online experiences, announced today that Shell Point has launched the company’s atlas3D platform....
Ambarella to Present at the Needham Growth Conference Jan. 10
Jan 03, 2017 13:00 pm UTC| Business
SANTA CLARA, Calif., Jan. 03, 2017 -- Ambarella, Inc. (NASDAQ:AMBA), a leading developer of low-power, HD and Ultra HD video compression and image processing semiconductors, today announced that Dr. Fermi Wang, CEO, and...
G1 Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2017 -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present a company overview at the 35th...
Aclaris to Present at 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:00 pm UTC| Business
MALVERN, Pa., Jan. 03, 2017 -- Aclaris Therapeutics, Inc.(NASDAQ:ACRS), a dermatologist-led clinical-stage pharmaceutical company focused on defining new standards of care in medical and aesthetic dermatology, today...
Jan 03, 2017 13:00 pm UTC| Business
CAMBRIDGE, Mass., Jan. 03, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler,...